FDA Investigator Tyanna N Hadley

Tyanna N Hadley has conducted inspections on 43 sites in 3 countries as of 13 May 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
43
Last Inspection Date:
13 May 2024
Investigator Role:
FDA Investigator
Redica ID:
100008993
Countries of Inspections:
United States of America, Switzerland, Korea (Republic of)
FDA Investigators that have inspected at least one site in common with Tyanna N Hadley:
Addam S Reynolds, Adetutu M Gidado, Alberto A Viciedo, Alice S Tsao, Allen Lou, Amy A Johnson, Amy L Singer, Anastasia I Offordile, Ankur C Patel, Anna R Kwilas, Annemarie Bodnar, Anthony Kovalenko, Asia D Clark, Barbara Jwilimczyk Macri, Bijoy Panicker, Byungja E Marciante, Charles J Chacko, Cheryl A Grandinetti, Christina N Maurino, Christopher Janik, Cody D Rickman, Daniel J Min, Darin S Wiegers, David A Oluwo, David H Smith, Dawn L Wydner, Deborah B Nixon, Demitria J Xiradakis, Denise M Visco, Investigator, Diane C Thibodeau, Dien N Nguyen, Dorothy J Denes, Douglas C Kovacs, Dr. Robert C Horan, MD, Eduardo L Rodriguez, Emest F Bizjak, Emily A Walters, Emmanuel Jramos Maldonado, Eric Rothschild, Erin D Mccaffery, Feiyan Jin, Frederick F Razzaghi, Gam S Zamil, George Pyramides, Guerlain Ulysse, Haley H Seymour, Helen B Ricalde, James R Birkenstamm, Jay B Shah, Jay T Wong, Jean Blackston Hill, Jean M Kelahan, Jo Annc Declement, Joan A Loreng, Joanne M Schlossin, Jogy George, Jonee J Mearns, Jose M Cayuela, Joy P Matthias, Justine Tomasso, Karen E D'orazio, Karen L Kosar, Kassa Ayalew, MD, Kathleen B Swat, Kelli F Dobilas, Kent A Conforti, Kimberly L Schultz, Kristy A Zielny, Lata C Mathew, PhD, Lenahan Lenahan, Peter R, Leon L Crawley, Liatte Kreuger, PharmD, Linda Thai, Lisa Harlan, Loretta Nemchik, Marcelo O Mangalindan, Jr, Margaret M Sands, Mark R Mcclain, Matthew A Spataro, Maya M Davis, Mayar M Mussa, Melissa T Roy, Meredith L Sheridan, Michael F Skelly, PhD, Michael R Klapal, Michael Serrano, Michael Skelly, Michelle A Marsh, Nerizza B Guerin, Nicholas A Violand, Niketa Patel, Nimmy Mathews, Nina Yang, Odera I Ekwunife, Paul E Stein, Paul L Bellamy, Peter R Lenahan, Puspa Suresh Jayasekara, Regina T Brown, Richard M Fejka, Robert G Ruff, Robert Jennings, Rodney T Allnutt, Rose Ljean Mary, Ruth A Williams, Sandra Kershaw, Satheesh Thomas, Shirley S Wen, Simone E Pitts, Sony Mathews, Srinivas R Chennamaneni, PhD, Stephanie T Durso, Stephen J Mottola, Stephen R Souza, Tanya R Syffrard, Tonia F Bernard, Unnee Ranjan, Yangmin Ning, Yvesna C Blaise

Tyanna N Hadley's Documents

Publish Date Document Type Title
May, 2022 FDA 483 Dr. Reddy's Laboratories, Inc. - Form 483, 2022-05-26
July, 2023 FDA 483 Suneet Mittal, MD - Form 483, 2023-07-11
November, 2021 FDA 483 Ascend Laboratories, LLC - Form 483, 2021-11-10
March, 2022 EIR CELGENE CORPORATION - EIR, 2022-03-14
November, 2021 EIR Ascend Laboratories, LLC - EIR, 2021-11-10
August, 2022 FDA 483 Eli L. Diamond, MD - Form 483, 2022-08-24
August, 2023 FDA 483 Novartis Pharmaceuticals Corporation - Form 483, 2023-08-21
March, 2024 FDA 483 APPCO PHARMA LLC - Form 483, 2024-03-11
October, 2021 FDA 483 Aquestive Therapeutics Inc. - Form 483, 2021-10-07
March, 2022 FDA 483 BioClinica, Inc. - Form 483, 2022-03-04
March, 2023 FDA 483 Ferring Pharmaceuticals Inc - Form 483, 2023-03-14
April, 2022 FDA 483 Inci B. Yildirim, M.D. - Form 483, 2022-04-15
January, 2022 EIR BioClinica, Inc. - EIR, 2022-01-10
June, 2023 FDA 483 Cassie L. Blanchard, PhD - Form 483, 2023-06-13
October, 2021 EIR Aquestive Therapeutics Inc. - EIR, 2021-10-07
September, 2022 FDA 483 Ascent Pharmaceuticals Inc - Form 483, 2022-09-15
October, 2021 FDA 483 Mitsubishi Tanabe Pharma Development America, Inc. - Form 483, 2021-10-15
March, 2023 FDA 483 SpringWorks Therapeutics, Inc. - Form 483, 2023-03-31
December, 2021 FDA 483 Robert Wood Johnson U Hosp @ Hamilton IRB - Form 483, 2021-12-22
March, 2023 EIR SpringWorks Therapeutics, Inc. - EIR, 2023-03-31
January, 2024 FDA 483 Rocket Pharmaceuticals, Inc. - Form 483, 2024-01-25
October, 2022 FDA 483 Argenta - Form 483, 2022-10-28
February, 2023 FDA 483 AtlantiCare Regional Medical Center IRB - Form 483, 2023-02-23
October, 2023 FDA 483 Purdue Pharma L.P. - Form 483, 2023-10-05
October, 2021 EIR Mitsubishi Tanabe Pharma Development America, Inc. - EIR, 2021-10-15
September, 2022 EIR Ascent Pharmaceuticals Inc - EIR, 2022-09-15
June, 2023 FDA 483 Michael A. Hassman, DO - Form 483, 2023-06-20
March, 2024 FDA 483 Steven J. Glass, M.D. - Form 483, 2024-03-25
November, 2021 EIR Ascend Laboratories, LLC - EIR, 2021-12-17
November, 2023 FDA 483 Howard A. Hassman, D.O. - Form 483, 2023-11-20
April, 2024 FDA 483 Intercept Pharmaceuticals, Inc. - Form 483, 2024-04-22
October, 2024 FDA 483 Actelion Pharmaceuticals US Inc. - Form 483, 2024-10-28
July, 2022 FDA 483 Pierre Fabre Dermo Cosmetique - Form 483, 2022-07-29

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more